Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. (Nasdaq: ESLA) is a clinical-stage biopharmaceutical company focused on immunology and oncology therapeutics. The company filed an amended registration statement on Form S-1/A with the SEC on December 18, 2023 (accession no. 0001213900-23-096259), advancing its path to a public listing within the life sciences and biopharma sector. The filing reflects the company's ongoing regulatory process as it works to bring its pipeline to public markets. Estrella Immunopharma is among the clinical-stage issuers tracked on SpacDesk for investors monitoring SPAC-adjacent and emerging biopharma deal flow. Sign up at SpacDesk for full filing history, deal timelines, and real-time data on Estrella Immunopharma and hundreds of other SPAC-linked companies.